CD22L-N3

Overview

CD22L-N3 (BPC-Sia-LacNAc-N3) is a pharmaceutical intermediate that can be used to synthesize CD22 -specific trisaccharide ligands. CD22L-N3 is applicable to the research of B-cell lymphoma.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Others | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Drug Intermediate

Product Information

• Catalog No.: HY-184482
• CAS No.: 1019642-47-7
• Molecular Formula: C40H54N6O19
• Molecular Weight: 922.90
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source